Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OB VEGA-Phenylephrine vs Norepinephrine Outcomes
NCT07900919Phase 4Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2027
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypotension comparing Phenylephrine with Norepinephrine (2 arms). Primary endpoints: Change in Uterine tone-obstetrician evaluation scores up to 2 hours, Change in Uterine tone-obstetrician evaluation scores with Uterine tone-uterotonic drug administration up to 2 hours and 2 more. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
phenylephrinenorepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT07900919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07900919.